HighTower Advisors
AXNX

HighTower Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

HighTower Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,880
Closed -$390K – 3452
2022
Q2 		$390K Buy
6,880
+48
+0.7% +$2.63K ﹤0.01% 2205
2022
Q1 		$428K Buy
6,832
+30
+0.4% +$1.62K ﹤0.01% 2286
2021
Q4 		$381K Buy
6,802
+115
+2% +$7.03K ﹤0.01% 2338
2021
Q3 		$435K Sell
6,687
-2,428
-27% -$166K ﹤0.01% 2150
2021
Q2 		$575K Buy
9,115
+2,252
+33% +$133K ﹤0.01% 1973
2021
Q1 		$411K Sell
6,863
-3,280
-32% -$178K ﹤0.01% 2105
2020
Q4 		$506K Buy
10,143
+67
+0.7% +$3.15K ﹤0.01% 1639
2020
Q3 		$514K Buy
10,076
+176
+2% +$7.35K ﹤0.01% 1555
2020
Q2 		$348K Hold
9,900
– – ﹤0.01% 1640
2020
Q1 		$252K Buy
+9,900
New +$294K ﹤0.01% 1661

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HighTower Advisors's AXNX Position: Q3 2022 in Review

HighTower Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2022, closing a stake of 6,880 shares — an estimated $390K sold.

HighTower Advisors first reported a position in AXNX in Q1 2020 and held it in 10 quarters. The position peaked at $575K in Q2 2021. 230 funds tracked by Wall St. Rank hold AXNX as of Q3 2022.

  • HighTower Advisors reported no remaining Axonics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 6,880 Axonics, Inc. Common Stock shares in Q3 2022, an estimated $390K.
  • HighTower Advisors first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • HighTower Advisors's Axonics, Inc. Common Stock position peaked at $575K in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.